| Company Name: |
TargetMol Chemicals Inc.
|
| Tel: |
15002134094 |
| Email: |
marketing@targetmol.cn |
| Products Intro: |
Product Name:LRRK2/NUAK1/TYK2-IN-1 CAS:2629192-96-5 Package:25mg/RMB 10600;50mg/RMB 13800;100mg/RMB 17500
|
Pyrazolo[4,3-d][1,3]benzodiazepine, 5-(2,6-difluorophenyl)-9-fluoro-2,4-dihydro-8-(4-pyridazinyl)- manufacturers
- LRRK2/NUAK1/TYK2-IN-1
-
- $1520.00 / 25mg
-
2025-10-27
- CAS:2629192-96-5
- Min. Order:
- Purity:
- Supply Ability: 10g
|
| | Pyrazolo[4,3-d][1,3]benzodiazepine, 5-(2,6-difluorophenyl)-9-fluoro-2,4-dihydro-8-(4-pyridazinyl)- Basic information |
| Product Name: | Pyrazolo[4,3-d][1,3]benzodiazepine, 5-(2,6-difluorophenyl)-9-fluoro-2,4-dihydro-8-(4-pyridazinyl)- | | Synonyms: | Pyrazolo[4,3-d][1,3]benzodiazepine, 5-(2,6-difluorophenyl)-9-fluoro-2,4-dihydro-8-(4-pyridazinyl)-;5-(2,6-Difluorophenyl)-9-fluoro-8-(pyridazin-4-yl)-2,4-dihydrobenzo[d]pyrazolo[3,4-f][1,3]diazepine;LRRK2/NUAK1/TYK2-IN-1 | | CAS: | 2629192-96-5 | | MF: | C20H11F3N6 | | MW: | 392.34 | | EINECS: | | | Product Categories: | | | Mol File: | 2629192-96-5.mol | ![Pyrazolo[4,3-d][1,3]benzodiazepine, 5-(2,6-difluorophenyl)-9-fluoro-2,4-dihydro-8-(4-pyridazinyl)- Structure](CAS/20210305/GIF/2629192-96-5.gif) |
| | Pyrazolo[4,3-d][1,3]benzodiazepine, 5-(2,6-difluorophenyl)-9-fluoro-2,4-dihydro-8-(4-pyridazinyl)- Chemical Properties |
| Boiling point | 744.9±60.0 °C(Predicted) | | density | 1.57±0.1 g/cm3(Predicted) | | pka | 12.95±0.20(Predicted) |
| | Pyrazolo[4,3-d][1,3]benzodiazepine, 5-(2,6-difluorophenyl)-9-fluoro-2,4-dihydro-8-(4-pyridazinyl)- Usage And Synthesis |
| Uses | LRRK2/NUAK1/TYK2-IN-1 (conpound 226) shows inhibitory activity toward LRRK2 (Wt), LRRK2 (G2019), TYK2 and NUAK1, with IC50 values lower than 10 nM. LRRK2/NUAK1/TYK2-IN-1 can be used for autoimmune disease research[1]. | | IC 50 | Tyk2; NUAK1 | | References | [1] Roland Koestler, et al. 1,4-dihydrobenzo[d]pyrazolo[3,4-f][1,3]diazepine derivatives and related compounds as lrrk2, nuak1 and/or tyk2 kinase modulators for the treatment of e.g. autoimmune disease. Patent WO2021048618A1. |
| | Pyrazolo[4,3-d][1,3]benzodiazepine, 5-(2,6-difluorophenyl)-9-fluoro-2,4-dihydro-8-(4-pyridazinyl)- Preparation Products And Raw materials |
|